SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes

André C. Ferreira; Vinicius Cardoso Soares; Isaclaudia G. de Azevedo-Quintanilha; Suelen da Silva Gomes Dias; Natalia Fintelman-Rodrigues; Carolina Q. Sacramento; Mayara Mattos; Caroline S. de Freitas; Jairo R. Temerozo; Lívia Teixeira; Eugenio Damaceno Hottz; Ester A Barreto; Camila R. R. Pão; Lohanna Palhinha; Milene Miranda; Dumith Chequer Bou-Habib; Fernando A. Bozza; Patrícia T. Bozza; Thiago Moreno L. Souza

doi:10.1101/2020.08.25.20182055

SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes

André C. Ferreira, Vinicius Cardoso Soares, Isaclaudia G. de Azevedo-Quintanilha, Suelen da Silva Gomes Dias, Natalia Fintelman-Rodrigues, Carolina Q. Sacramento, Mayara Mattos, Caroline S. de Freitas, Jairo R. Temerozo, Lívia Teixeira, Eugenio Damaceno Hottz, Ester A Barreto, Camila R. R. Pão, Lohanna Palhinha, Milene Miranda, Dumith Chequer Bou-Habib, Fernando A. Bozza, Patrícia T. Bozza, Thiago Moreno L. Souza

doi: https://doi.org/10.1101/2020.08.25.20182055

André C. Ferreira

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

2Laboratório de Pesquisa Pré-clínica - Universidade Iguaçu, Nova Iguaçu, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: andre.bio2009{at}gmail.com

Vinicius Cardoso Soares

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

9Program of Immunology and Inflammation, Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: andre.bio2009{at}gmail.com

Isaclaudia G. de Azevedo-Quintanilha

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Suelen da Silva Gomes Dias

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Natalia Fintelman-Rodrigues

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carolina Q. Sacramento

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mayara Mattos

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Caroline S. de Freitas

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jairo R. Temerozo

3Laboratório de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil

4National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lívia Teixeira

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eugenio Damaceno Hottz

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

5Laboratório de Imunotrombose, Departamento de Bioquímica, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ester A Barreto

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Camila R. R. Pão

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lohanna Palhinha

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Milene Miranda

6Laboratório de Vírus Respiratório e do Sarampo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dumith Chequer Bou-Habib

3Laboratório de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil

4National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fernando A. Bozza

7Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, RJ, Brazil

8Instituto D’or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patrícia T. Bozza

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thiago Moreno L. Souza

1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

10Centro De Desenvolvimento Tecnológico Em Saúde (CDTS), Fiocruz, Rio de Janeiro, Brasil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: andre.bio2009{at}gmail.com

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

The data supporting the results of this study are available as supplementary files on the website mendeley.com

View the discussion thread.

PreviousNext

Posted October 23, 2020.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes

medRxiv 2020.08.25.20182055; doi: https://doi.org/10.1101/2020.08.25.20182055

Share This Article:

Citation Tools

SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes

medRxiv 2020.08.25.20182055; doi: https://doi.org/10.1101/2020.08.25.20182055

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Infectious Diseases (except HIV/AIDS)

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)